BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
41 hedge funds and large institutions have $39.8M invested in BioSpecifics Technologies Corp. in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 6 closing their positions.
67% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 6
11% more funds holding
Funds holding: 37 → 41 (+4)
11% more capital invested
Capital invested by funds: $36M → $39.8M (+$3.81M)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$1.8M |
| 2 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$1M |
| 3 |
Renaissance Technologies
New York
|
+$563K |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$457K |
| 5 |
PAM
Paradigm Asset Management
New York
|
+$354K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$7.47M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$773K |
| 3 |
AC
Amici Capital
New York
|
-$620K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$333K |
| 5 |
LMF
LMR Master Fund
Grand Cayman,
Cayman Islands
|
-$181K |
BSTC Hedge Fund Activity: Q3 2013 in Review
41 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q3 2013, worth a combined $39.8M — up 11% from $36M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new BSTC positions and 6 closed out — a net gain of 4 holders — while 9 added to existing stakes and 15 trimmed.
The largest buyer was Northpointe Capital, opening a new position worth an estimated $1.8M. The largest seller was BlackRock Advisors, cutting an estimated $7.47M.
- 41 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q3 2013, up from 37 in Q2 2013.
- Funds reported $39.8M of BioSpecifics Technologies Corp. stock for Q3 2013, up 11% quarter-over-quarter.
- 10 funds opened new BioSpecifics Technologies Corp. positions in Q3 2013 and 6 closed out, a net change of +4 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q3 2013 was Northpointe Capital, an estimated $1.8M added.
- The largest BioSpecifics Technologies Corp. seller in Q3 2013 was BlackRock Advisors, an estimated $7.47M sold.
Based on aggregated 13F filings for Q3 2013.